KOL Identification

Whether it’s a champion or a critic, insights from the right person will make all the difference. We can identify and connect you to the top, most influential minds in your space.

Our Experts

Pranay Madan

Katie Maloney

Carl Schoellhammer

Schedule a Call

Related Client Results

All Client Results

Financial Services

High-Level Commercial Due Diligence in Digital Pathology

An early-stage venture firm requested a high-level commercial due diligence of a potential investment

View

Due Diligence

Clinical Diagnostics

Diagnostic Advisory Board

A diagnostics company requested DeciBio to help an advisory board (ad board) to understand how to position its relatively new somatic oncology genomics profiling product in an already competitive market

View

Voice-of-Customer Research

KOL Identification

Research Tools

RWD Biobank Offering Go-to-Market Strategy

The ventures arm of a top-20 U.S. health system sought support developing a go-to-market strategy for RWD-augmented biobank offerings

View

Voice-of-Customer Research

Go-to-Market Strategy

Pricing Strategy

Competitive Analysis

Pharma & Biotech

Clinical, Genomic, and Pathology Real-World Data (RWD) Market Landscape Assessment

A real-world data (RWD) provider wanted to identify key use cases, unmet needs, and future opportunities in the RWD market, with a particular focus on clinical, genomic, and pathology RWD and biopharma users.

View

Voice-of-Customer Research

Pricing Strategy

Competitive Analysis

Clinical Diagnostics

Genetic Testing Company Assessment

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

View

Target Identification

Clinical Diagnostics

IVDR Opportunity Assessment

A top-10 diagnostics company wanted to gauge preparedness and reactions to implementation of IVDR, and how that would impact a potential new product

View

Voice-of-Customer Research

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch